23andMe to share customer gene data with GlaxoSmithKline for $300M

Re:23andMe to share customer gene data with GlaxoSmithKline ... by danudey on Tuesday December 17, 2019 @01:40PM (#21817007)

Personally, I can't wait for the inevitable medical breakthroughs discovered through the service that we paid for, that GSK will sell back to us for thousands of dollars per treatment.

There's something so purely dystopian about paying a company to collect our genomic data, which then helps to create medical breakthroughs that none of us will be able to afford.

[ Parent | on HN ]

Re:23andMe to share customer gene data with GlaxoSmithKline ... by downvoted on Tuesday December 17, 2019 @03:43PM (#21818589)

And though the idea is tricky, commercializing our genome is no longer about "hey, the next R&D breakthrough will come from your genome." It's about making sure that the first humans to create such breakthroughs can get rich off the money it pays for them.

This is why it's so important that companies refrain from selling our genomes to biotech companies.

[ Parent | on HN ]

Re:23andMe to share customer gene data with GlaxoSmithKline ... by trixie_ on Tuesday December 17, 2019 @08:12PM (#21820836)

Wouldn't you be paying for all the R&D that was required after using the genetic info to develop a treatment.

If the treatment ends up costing $100k, the genetic info you provided resulted in a discount from infinite dollars to an actual finite amount.

That's a pretty big discount.

[ Parent | on HN ]